Autologous Stem Cell Transplantation

Pipeline Programs↗

Active Trials↗

Companies Involved↗

Autologous Stem Cell Transplantation is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

53/100

Attrition Rate

39/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

clinical trials

Completed8 · 44%

Terminated6 · 33%

Unknown status2 · 11%

Withdrawn1 · 6%

Recruiting1 · 6%

Clinical Trials

Trial Activity

18 trials

Autologous Stem Cell Transplantation for Crohn's Disease

Recruiting·—·Phase 1/2·NCT00692939·20 enrolled

High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT00231582·50 enrolled

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation

Completed·—·Phase 1·NCT00083135·18 enrolled

Zevalin/BEAM/Rituximab vs BEAM/Rituximab With or Without Rituximab in Autologous Stem Cell Transplantation

Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00591630·30 enrolled

Effect of Vitamin C in Autologous Stem Cell Transplantations

Completed·MMaastricht University Medical Center·Phase 2·NCT03964688·47 enrolled

Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma

Completed·UUniversity of Pennsylvania·Phase 2·NCT01245673·28 enrolled

Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation

Completed·NNantes University Hospital·Phase 2/3·NCT01015196·832 enrolled

Use of Zarzio® in Post-autologous Stem Cell Transplantation Procedure

Completed·UUniversity Hospital, Brest·N/A·NCT03323541·62 enrolled

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

Completed·UUniversity of Nebraska·Phase 1/2·NCT00031642·26 enrolled

High Dose Chemotherapy With Amifostine and Autologous Stem Cell Transplantation for High Risk Relapsed Pediatric Solid Tumors and Brain Tumors

Terminated·—·Phase 2·NCT05167370·2 enrolled

Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients

Terminated·SShanghai Jiao Tong University School of Medicine·Phase 2/3·NCT00984828·23 enrolled

Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation

Terminated·UUniversity of Nebraska·Phase 2·NCT02700841·8 enrolled

Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation

Terminated·TTufts Medical Center·Phase 1·NCT01610999·7 enrolled

Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence

Terminated·HHackensack Meridian Health·Phase 1/2·NCT02681302·46 enrolled

Phase II Study of V-BEAM Conditioning Regimen Prior to Second Autologous Stem Cell Transplantation

Terminated·WWashington University School of Medicine·Phase 2·NCT01653418·10 enrolled

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)